Biocross 5 LPM vs Philips Everflo 5 Liter Oxygen Concentrator

The Biocross 5 LPM versus Philips Everflo 5 LPM is one of the clearer matchups in this review series. The two units are Rs. 7,219 apart in price — meaningful money but not decisive for most buyers — and they sit on opposite ends of the “documentation quality” spectrum that defines the Indian 5 LPM market. The Biocross is a Chinese-origin budget unit with a spec sheet that leaves every safety-feature row and every certification row blank. The Philips Everflo is the American-engineered LTOT benchmark with full alarm coverage, FDA and CE approval, and a 10+ year Indian market track record. At this modest price gap, the matchup is not really a matchup — it is a demonstration of what a Rs. 7,219 premium buys at the Indian 5 LPM price band.

Price and availability

Biocross 5 LPM: Rs. 36,480 street price, no MRP listed. Out of Stock on the surveyed Indian e-commerce listing. No customer ratings visible.

Philips Everflo 5 LPM: Rs. 43,699 street price against an MRP of Rs. 63,228.48 (31 percent discount). In Stock. 128 verified customer ratings at 4.9 average.

The Philips is Rs. 7,219 more expensive than the Biocross — a 20 percent premium. Not trivial, but in the context of a three-to-five-year medical-device purchase, not prohibitive for most Indian middle-class households that have been quoted for LTOT.

Stock tells its own story. The Philips is In Stock. The Biocross is Out of Stock. For a post-discharge patient who needs oxygen within 48-72 hours, the Biocross is not a purchasable option today regardless of price.

Flow, purity, weight

Both units deliver flow in the 5 LPM class. The Biocross lists 0.5-5 LPM continuous; the Philips lists 1-5 LPM continuous. Biocross purity 90-95%; Philips purity 90-96%. The Philips’s upper 96% on the purity band is a one-percent lead within PSA noise.

The Biocross’s lower 0.5 LPM floor is theoretically useful for paediatric and titration-sensitive cases, but in the Indian adult LTOT context where most prescriptions sit at 2-4 LPM, the flow-floor advantage does not translate into real clinical utility.

Weight: Biocross 16 kg. Philips 14 kg. The Philips is 2 kg lighter — 12.5 percent less. For household repositioning, caregiver lifting, and general handling, the Philips is genuinely easier to manage.

Footprint: Biocross 21H x 11.8W x 12D inch. Philips 23H x 15W x 9.5D inch. The Philips is taller and wider but meaningfully shallower. 9.5 inches of depth versus 12 inches makes the Philips sit closer to the wall in Indian bedrooms, which is almost always the binding constraint.

Sound

Biocross: 48 dB. Philips: 45 dB.

Three decibels is perceptible. The Philips sits in the “bedroom acceptable for most users” zone at 45 dB, while the Biocross at 48 dB is in the “bedroom acceptable for habituated users” zone. For nocturnal LTOT, the Philips is the quieter housemate.

Power

Biocross: 320 W. Philips: 350 W.

The Philips draws 9 percent more power than the Biocross. At 14 hours per day on Mumbai rates, the difference is approximately Rs. 100 per month — roughly Rs. 1,200 per year. Not a material operating-cost delta.

Outlet pressure

Biocross: 12 psi. Philips: 5.5 psi.

The Biocross’s outlet pressure is substantially higher — over twice the Philips’s 5.5 psi. For installations with long cannula runs (40+ feet for multi-room or whole-house distribution), the Biocross’s 12 psi preserves flow at the patient end more reliably. For typical bedside placement with 7-10 feet of tubing, either pressure delivers adequate flow.

This is the one axis on which the Biocross materially outperforms the Philips.

OPI and alarms: the widest gap in the matchup

Biocross 5 LPM spec sheet: Oxygen Purity Indicator blank. Oxygen Purity Analyzer blank. Loss of Power Alarm blank. System Malfunction Alarm blank. No Flow Alarm blank. Company Headquarters China. US FDA blank. FAA blank. CE blank. Indian Voltage Model Yes.

Philips Everflo 5 LPM spec sheet: Oxygen Purity Indicator Yes. Loss of Power Alarm Yes. System Malfunction Alarm Yes. No Flow Alarm Yes. Oxygen Purity Analyzer blank. Company Headquarters USA. US FDA Approved Yes. CE Certified Yes. Indian Voltage Model Yes.

The Biocross sheet has every safety-feature row and every certification row blank. Not a single documented alarm. No OPI. No FDA. No CE. The only “Yes” entry is Indian Voltage Model.

The Philips sheet has OPI and three of four alarms populated. US FDA Approved and CE Certified. Full documentation.

This is not a subtle gap. A home oxygen concentrator with no documented alarms is a unit that cannot warn the family during a power cut, cannot warn the family when the cannula kinks or disconnects, cannot warn the family when a compressor fault arises, and cannot warn the family when sieve-bed purity has degraded past clinical usefulness. Every failure mode home LTOT is susceptible to is invisible on the Biocross as documented. The machine may in fact have some of these features — Chinese-OEM units often do ship with features that are not documented on Indian-market collateral — but for a medical-device purchase, the paperwork is what the buyer has to rely on, and the Biocross paperwork is empty.

The Philips’s OPI lights up if purity falls below 82% per the manufacturer description. The loss-of-power alarm wakes caregivers during overnight grid interruptions. The system-malfunction alarm catches compressor fault conditions. The no-flow alarm triggers when the cannula is blocked or disconnected. These are the four alarms clinicians consider the minimum baseline for home LTOT, and the Philips has all of them documented.

Certifications

Biocross: Nothing. China HQ.

Philips: US FDA Approved. CE Certified. USA HQ.

The Philips’s FDA 510(k) clearance covers alarm function testing, electrical safety (IEC 60601-1), EMC (EN 55011 / 60601-1-2), and performance claims. CE marking covers European conformity to equivalent standards. These certifications are not merely paperwork — they indicate the unit has passed independent engineering validation, which Chinese-OEM budget units typically have not undergone.

For Indian institutional procurement (hospitals, NGOs, insurance-covered home care), FDA approval is frequently a procurement requirement that rules out units like the Biocross. For private individual buyers, the certifications are a quality signal.

Warranty and service

Biocross: warranty period not visible on the surveyed spec sheet.

Philips Everflo: 3-year warranty per the manufacturer description.

The Philips’s 3-year warranty is class-leading, matching the Nidek Nuvo Lite and Oxymed Mini. The Biocross’s absent warranty number on the surveyed sheet is a concerning paperwork gap.

Philips Respironics operates an Indian service channel through authorised distributors with spares availability in major Indian cities. The Biocross’s Indian service reachability is dealer-dependent — the brand does not operate visible factory-backed support in India.

Rating signal

Philips: 128 verified customer ratings at 4.9 average. A meaningful track record over multiple years of Indian sales.

Biocross: no ratings visible on the surveyed listing.

Verdict

The Philips Everflo 5 LPM is the correct choice over the Biocross 5 LPM by essentially every measure: safety features (OPI plus three alarms vs zero documented), certifications (FDA plus CE vs none), weight (2 kg lighter), sound (3 dB quieter), warranty (3 years vs undocumented), service network (Philips Respironics Indian channel vs dealer-dependent), rating signal (128 ratings vs zero), and availability (in stock vs out of stock).

The Biocross’s only measurable advantages are Rs. 7,219 lower price and 12 psi outlet pressure — the latter useful only for long tubing runs that are rare in typical bedside LTOT installations.

For Rs. 7,219, the Philips Everflo delivers documented OPI, three alarms, FDA approval, CE certification, and a 3-year warranty. There is no serious buyer profile for which the Biocross is the right choice over the Philips at this price gap.

If the Rs. 7,219 is genuinely the binding constraint for a particular household’s budget — i.e., the buyer cannot afford the Philips at all — the appropriate alternative is not the Biocross but a different Indian-made unit in the Rs. 30,000-36,000 band with at least some documented safety features. The Oxymed Mini 5 LPM at Rs. 35,400 (full alarm coverage, live purity analyser, CDSCO registered, 3-year warranty, 1,062 verified ratings) is a far better budget alternative than the Biocross and is within Rs. 1,000 of the Biocross’s price point. The Dr Diaz 5 LPM at Rs. 29,759 (OPI plus three alarms, India HQ, 12,000-feet altitude) is cheaper than the Biocross and substantially better specified.

The Biocross 5 LPM is the unit to pick only when price is the absolute binding constraint and no Indian-made alternative with documented safety features can be stretched to. That is a narrow profile.

Provenance note: all product specifications referenced in this writeup are drawn from the respective manufacturer brochures and Indian e-commerce product listings surveyed in April 2026. No bench testing has been conducted by HHZ Editorial; no clinical claims are made beyond what manufacturer documentation supports. Indian LTOT decisions should be made in consultation with the prescribing physician.